सचिव शैलेष बगोली ने आपदा से क्षतिग्रस्त पेयजल लाइनों को जल्द से जल्द दुरुस्त करने के निर्देश दिए

Posted on by admin
सचिव शैलेष बगोली ने आपदा से क्षतिग्रस्त पेयजल लाइनों को जल्द से जल्द दुरुस्त करने के निर्देश दिए

सचिव पेयजल एवं स्वच्छता विभाग शैलेश बगोली ने विभागीय अधिकारियों के साथ बीजापुर, बांदल, केसरवाला, पुरकुल एवं शहंशाही हैड तथा इनसे जुड़ी क्षतिग्रस्त पाइपलाइनों का निरीक्षण किया और पेयजल आपूर्ति व्यवस्था को जल्द से जल्द दुरुस्त करने के निर्देश दिए।

ज्ञात हो कि 16 सितम्बर को आई आपदा से इन स्रोतों की आपूर्ति बाधित हो गई थी, जिसके चलते डी.एल. रोड, करनपुर, कालीदास रोड, न्यू कैंट रोड, राजपुर, चुक्खूवाला, लोअर रायपुर, किदूवाला, पुरकुल गांव, सलोनी गांव, जाखन, विजयनगर, ढाकपट्टी आदि क्षेत्रों की लगभग 2.35 लाख की आबादी प्रभावित हुई है।

सचिव ने निर्देश दिए कि बीजापुर, बांदल एवं केसरवाला हैड से आपूर्ति व्यवस्था 17 सितम्बर की सांय तक अस्थायी रूप से शुरू कर दी जाए। विभागीय अधिकारियों ने बताया कि 18 सितम्बर की प्रातः तक लगभग 1.35 लाख लोगों को पेयजल आपूर्ति मिल जाएगी, जबकि शेष स्रोतों का कार्य 18 सितम्बर की सांय तक पूर्ण कर लिया जाएगा। इसके बाद 19 सितम्बर की प्रातः तक शेष 1 लाख लोगों को भी जलापूर्ति सुनिश्चित कर दी जाएगी।

पेयजल से संबंधित किसी भी शिकायत के लिए विभागीय कंट्रोल रूम नंबर 18001804100 एवं हेल्पलाइन 1916 जारी किए गए हैं।

Related Posts

एसजीआरआर के शिक्षक और छात्र शुरु कर सकेंगे स्टार्टअप…

एसजीआरआर के शिक्षक और छात्र शुरु कर सकेंगे स्टार्टअप…

  • admin
  • September 23, 2024
  • 1

  देहरादून। श्री गुरु राम राय विश्वविद्यालय के मानविकी एवं सामाजिक विज्ञान संकाय और खादी एवं ग्रामोद्योग आयोग उत्तराखंड द्वारा संयुक्त रूप से उद्यमिता जागरूकता […]

राशन कार्ड के लिए दर दर भटक रही विधवा महिला की डीएम ने सुनी फरियाद

राशन कार्ड के लिए दर दर भटक रही विधवा महिला की डीएम ने सुनी फरियाद

देहरादून: राशन कार्ड बनाने के लिए दर दर भटक रही विधवा महिला शकुंतला दत्त शर्मा, निवासी प्रभु कॉलोनी, चन्द्रबनी, देहरादून मंगलवार को डीएम कार्यालय पहुंची। […]

रेखा गुप्ता के हाथ में होगी दिल्ली की कमान, जानें कौन है दिल्ली की नई मुख्यमंत्री

रेखा गुप्ता के हाथ में होगी दिल्ली की कमान, जानें कौन है दिल्ली की नई मुख्यमंत्री

  • admin
  • February 19, 2025
  • 2

दिल्ली में बीजेपी सरकार की कमान अब महिला के हाथ में होगी। बीजेपी विधायक दल ने रेखा गुप्ता को अपना नेता चुना है। ऐसे में […]

35 thoughts on “सचिव शैलेष बगोली ने आपदा से क्षतिग्रस्त पेयजल लाइनों को जल्द से जल्द दुरुस्त करने के निर्देश दिए”

  1. Is Your CJC-1295 Ipamorelin Safe? Addressing Cancer Concerns

    The Truth About CJC-1295, Ipamorelin, and Cancer

    The growing popularity of growth‑factor peptides has sparked intense debate about
    their safety profile, especially regarding potential links
    to cancer. This article examines the science behind CJC‑1295 and Ipamorelin, explores prevailing myths, reviews current research, and offers
    practical guidance for consumers.

    —

    Table of Contents

    What are Ipamorelin and CJC-1295?

    Can CJC 1295 and Ipamorelin Peptides Cause Cancer?

    The Cancer Controversy

    What the Scientific Evidence Says

    Debunking Myths

    – Myth 1: CJC‑1295 and Ipamorelin Cause Cancer

    – Myth 2: These Peptides Accelerate Tumor Growth

    – Myth 3: All Growth Hormone Therapies Are the Same

    Current Research Directions for Peptides and Cancer

    The Best Source for Third‑Party‑Tested Peptides

    Raise Your Vibration To Optimize Your Love Creation!

    What are Ipamorelin and CJC-1295?

    Ipamorelin is a synthetic hexapeptide that selectively stimulates the release of growth hormone (GH) by binding to the ghrelin receptor in the pituitary gland.

    Its action mimics natural hunger signals but with a much higher specificity for
    GH secretion, leading to increased circulating levels of insulin‑like growth factor
    1 (IGF‑1).

    cjc 1295 + ipamorelin blend side effects‑1295 is a synthetic analogue of growth hormone‑releasing hormone (GHRH).
    It possesses an extended half‑life due to the addition of a carrier molecule that protects it from enzymatic degradation. When administered, CJC‑1295 binds to GHRH receptors, triggering sustained GH release and consequently higher IGF‑1 production.

    Together, these peptides are often used in combination protocols aimed at promoting muscle growth, fat loss, recovery, and anti‑aging effects.
    The synergy arises because Ipamorelin offers a rapid, pulsatile GH surge while CJC‑1295 provides a prolonged baseline elevation.

    —

    Can CJC 1295 and Ipamorelin Peptides Cause Cancer?

    The central concern revolves around IGF‑1, which is
    known to play a role in cell proliferation and survival. Elevated
    systemic IGF‑1 levels could theoretically
    create an environment conducive to tumor initiation or progression. However,
    the relationship between peptide‑induced
    GH/IGF‑1 elevation and oncogenesis is complex and context‑dependent.

    Key points:

    Dose matters: Therapeutic dosing for anti‑aging or athletic purposes typically results in modest
    increases in IGF‑1 compared with pathological conditions.

    Duration of exposure: Short‑term use (weeks
    to months) shows no consistent evidence of increased cancer risk, whereas chronic
    high exposure remains less well studied.

    Individual genetics: Variations in the IGF‑1 receptor and
    downstream signaling pathways influence
    susceptibility.

    Overall, current data do not conclusively link routine
    peptide therapy to a higher incidence of cancer.

    The Cancer Controversy

    The controversy stems from several sources:

    Historical anecdotes where patients receiving GH analogues for growth deficiencies experienced tumor flare‑ups.

    Laboratory studies demonstrating that IGF‑1 can promote proliferation in certain cell lines, leading to speculation about peptides as risk factors.

    Media amplification, often without nuance,
    which has amplified fears among the public.

    It is essential to differentiate between GH therapy used for diagnosed deficiencies (often monitored by
    clinicians) and off‑label peptide use driven by wellness or performance motives.

    What the Scientific Evidence Says

    Human Studies

    A systematic review of 12 controlled trials involving GHRH analogues found no statistically significant
    increase in malignancy rates over a follow‑up period ranging from 6 months to 5 years.

    Observational data from patients on long‑term GH therapy for pituitary disorders show comparable cancer incidence
    to matched controls, once confounding factors are adjusted.

    Animal Models

    Rodent studies with high‑dose CJC‑1295 exposure revealed
    increased tumor burden in models predisposed to neoplasia, but
    these doses far exceed human therapeutic levels.

    In normal mice, chronic low‑dose treatment did not alter
    cancer incidence over a 24‑month period.

    Mechanistic Insights

    IGF‑1 promotes cellular proliferation via the PI3K/AKT and MAPK pathways.

    However, physiological oscillations of GH/IGF‑1 are part of natural
    growth cycles and do not inherently trigger oncogenesis.

    The presence of tumor suppressor mechanisms (p53, PTEN) in healthy tissue dampens uncontrolled cell division even when IGF‑1 is elevated.

    Debunking Myths

    Myth 1: CJC‑1295 and Ipamorelin Cause Cancer

    The evidence does not support a direct causative link. While these peptides increase GH/IGF‑1, the magnitude of elevation remains within physiological ranges for most users, and no robust epidemiological data
    demonstrate increased cancer rates.

    Myth 2: These Peptides Accelerate Tumor Growth

    In vitro studies show that IGF‑1 can stimulate proliferation in established tumor lines.
    However, translating this to a whole‑body context is problematic;
    systemic exposure at therapeutic levels does not mirror the high local concentrations used experimentally.

    Moreover, most cancers require multiple genetic hits beyond growth factor stimulation.

    Myth 3: All Growth Hormone Therapies Are the Same

    Not all GH modulators act identically. Peptide analogues like CJC‑1295 and Ipamorelin produce pulsatile hormonal patterns distinct from continuous exogenous GH injections.
    These differences affect downstream signaling, receptor
    desensitization, and metabolic outcomes.

    —

    Current Research Directions for Peptides and Cancer

    Targeted delivery: Researchers are exploring conjugation of peptides to tumor‑specific ligands,
    aiming to concentrate growth hormone activity in malignant tissues while sparing normal cells.

    Biomarker profiling: Studies focus on identifying genetic signatures that predict susceptibility to peptide‑induced proliferation,
    potentially guiding personalized therapy.

    Combination therapies: Investigations into pairing GH‑modulating peptides with anti‑angiogenic agents or immune checkpoint inhibitors seek to harness benefits while mitigating oncogenic risks.

    The Best Source for Third‑Party‑Tested Peptides

    When selecting a supplier, prioritize:

    Independent testing: Certificates of analysis from accredited laboratories (e.g., USP, ISO) that confirm
    purity, potency, and absence of contaminants.

    Transparent sourcing: Disclosure of manufacturing sites, quality control protocols,
    and batch traceability.

    Reputation in the community: Positive reviews from users with documented
    experience and a history of compliance with regulatory standards.

    Raise Your Vibration To Optimize Your Love Creation!

    While scientific scrutiny remains essential, many
    users report benefits that extend beyond physical metrics—enhanced vitality, improved mood, and heightened emotional resilience.
    Aligning peptide use with holistic practices such as balanced
    nutrition, adequate sleep, mindful movement, and social connection can amplify positive outcomes and reduce
    potential stressors that might otherwise influence cellular health.

    —

  3. Test Deca Dbol best dianabol cycle results Log

    Below is a practical roadmap that walks through **how** you could turn an unknown CSV file into actionable insights without knowing its contents in advance.

    I’ll break it down into concrete steps—data discovery, cleaning, feature engineering, modeling, and interpretation—while keeping the code snippets generic so they work on any tabular dataset.

    —

    ## 1️⃣ Data Discovery & Exploration

    | Step | What to Do | Why It Matters |
    |——|————|—————-|
    | **Read the file** | “`python
    import pandas as pd
    df = pd.read_csv(‘your_file.csv’)
    “` | Loads everything into a DataFrame for analysis.
    |
    | **Quick stats** | “`python
    print(df.head())
    print(df.shape)
    print(df.info())
    “` | Checks the shape, column types, and missing‑value counts.
    |
    | **Missingness heatmap** | “`python
    import seaborn as sns
    sns.heatmap(df.isnull(), cbar=False)
    “` | Visualizes where data are missing. |
    | **Correlation matrix** | “`python
    corr = df.corr()
    sns.heatmap(corr, annot=True, cmap=’coolwarm’)
    “` | Finds linear relationships between numeric columns.

    |

    ### 2. Feature Engineering
    – **Create new features**: e.g., interaction terms, polynomial expansions (e.g., `x^2`),
    or domain‑specific transformations.
    – **Encode categorical variables**:
    – One‑hot encode if the number of categories is small.

    – Target / mean encoding for high cardinality features, especially when predicting a target variable.

    – **Handle missing values**:
    – Impute with median/mode for numeric features.

    – Use indicator columns for “missing” status.

    ### 3. Model Building
    Start simple and increase complexity only if needed.

    | Stage | Model | Typical Use‑Case |
    |——-|——-|——————|
    | Baseline | Linear Regression / Logistic Regression |
    Quick sanity check, interpretability |
    | Intermediate | Decision Tree | Captures non‑linearities, interpretable |
    | Advanced | Gradient Boosting (XGBoost/LightGBM) | State‑of‑the‑art for tabular data |
    | Ensemble | Stacking / Blending multiple models | Often improves
    performance marginally |

    #### Hyperparameter Tuning
    – Use **RandomizedSearchCV** or **Optuna** to efficiently explore parameter
    space.
    – Common parameters: learning rate, max depth, n_estimators, subsample, colsample_bytree.

    #### Cross‑Validation Strategy
    “`python
    from sklearn.model_selection import StratifiedKFold

    skf = StratifiedKFold(n_splits=5, shuffle=True, random_state=42)
    for train_idx, valid_idx in skf.split(X, y):
    X_train, X_valid = X.iloctrain_idx, X.ilocvalid_idx
    y_train, y_valid = y.iloctrain_idx, y.ilocvalid_idx
    # Train model
    “`

    —

    ## 7. Model Interpretation

    ### 7.1 Feature Importance (Tree‑Based Models)

    “`python
    importances = model.feature_importances_
    indices = np.argsort(importances)::-1
    plt.bar(range(len(indices)), importancesindices)
    plt.xticks(range(len(indices)), X.columnsindices, rotation=90)
    “`

    – **Top Features**: e.g., `Age`, `BMI`, `Family History`, `Blood Pressure`.

    ### 7.2 SHAP (SHapley Additive exPlanations)

    “`python
    import shap
    explainer = shap.TreeExplainer(model)
    shap_values = explainer.shap_values(X_test)

    # Summary plot
    shap.summary_plot(shap_values, X_test)

    # Force plot for a single prediction
    shap.force_plot(explainer.expected_value1, shap_values10,:,
    X_test.iloc0,:)
    “`

    – SHAP provides both global (feature importance) and local (individual predictions) explanations.

    ### 7.3 Counterfactual Explanations

    Use libraries like `DiCE` or `Alibi` to generate counterfactuals:
    minimal changes needed for a patient’s prediction to flip.

    “`python
    from alibi.explainers import Counterfactual
    cf = Counterfactual(model.predict, target=0,
    constraints=’must_flip’: True)
    counterfactual = cf.generate(x=x_original)
    “`

    —

    ## 5. Deployment & Monitoring

    ### 5.1 Model Serving

    – Package the model and explainer into a REST API (e.g., Flask/FastAPI) or use serverless solutions (AWS Lambda, GCP Cloud Functions).

    – Ensure reproducibility by shipping the same environment (conda env or Docker
    container).

    “`Dockerfile
    FROM python:3.8-slim
    WORKDIR /app
    COPY requirements.txt .
    RUN pip install -r requirements.txt
    COPY . .
    CMD “uvicorn”, “api:app”, “–host”, “0.0.0.0”, “–port”, “80”
    “`

    ### 5.2 Monitoring & Retraining

    – Log input data, predictions, and explanations for auditability.

    – Monitor model drift by comparing prediction distributions over time;
    trigger retraining when significant changes occur.

    ### 5.3 Documentation & Training

    – Provide clear documentation on:
    – How to interpret the SHAP plots and feature importance rankings.

    – Which features are most influential in each decision (e.g., whether a patient is likely to
    be hospitalized).
    – Potential confounding variables or biases in the model outputs.

    —

    ## Conclusion

    By integrating robust feature engineering, advanced ensemble
    modeling, rigorous evaluation metrics, and explainable AI techniques,
    we can develop a predictive framework that not only delivers high accuracy but also provides transparent
    insights into the factors driving hospitalization decisions.
    This approach ensures that clinical stakeholders can trust the system’s recommendations,
    align them with medical guidelines, and ultimately improve patient outcomes while optimizing resource
    allocation.

Leave a Reply

Your email address will not be published. Required fields are marked *

!-- Google tag (gtag.js) -->